Pregabalin Capsule 75 mg (Pregabalin)

Adult dosage

This medication is administered orally, divided into 2 doses per day, regardless of meals. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg per day can be administered, with a potential increase to 300 mg per day after 3-7 days, and if necessary, may be increased up to 600 mg per day at 7-day intervals. - Central neuropathic pain: Starting dose of 150 mg per day can be given, with an increase to 300 mg after a week. Further increase to a maximum of 600 mg may be possible a week later, based on patient response.

Children's dosage

Administration in children under 12 years and adolescents aged 12-17 is not recommended due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behaviors, so if symptoms of depression or mood changes occur during treatment, consult a doctor immediately. Do not take if you are allergic to any of the ingredients in this medication, and patients with specific genetic lactose metabolism disorders should avoid it as well. Diabetic patients may experience weight gain after taking this medication, which may require dosage adjustment of blood sugar control medications. If symptoms of angioedema, such as swelling around the face or neck, occur, stop taking the medication immediately and inform a healthcare professional. Elderly patients should be cautious as this medication may cause dizziness or drowsiness, increasing the risk of accidents such as falls. This medication may cause temporary blurred vision or changes in vision; if these symptoms occur, consult a doctor. Withdrawal symptoms, such as headaches, anxiety, and insomnia, may occur if the medication is discontinued abruptly, so gradual tapering is recommended, under the supervision of a healthcare professional. This medication has a risk of abuse, so patients should disclose their mental health status and medication history accurately to their healthcare provider. Patients with decreased kidney function may require dosage adjustments. Patients with severe heart disease should use caution when taking this medication. When taken with other CNS depressants, the risk of drowsiness or respiratory depression may increase, so caution is advised. Early pregnancy poses a risk of fetal malformations; therefore, pregnant women or those planning to become pregnant should consult a doctor, and fertile women should use effective contraception. Breastfeeding may transfer this medication into breast milk and affect the baby, so consult a healthcare provider regarding breastfeeding. This medication can cause dizziness and drowsiness, so it is advisable to avoid driving or operating dangerous machinery after taking it. In cases of overdose, severe drowsiness, confusion, depression, etc., may occur; seek medical attention immediately.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (skin or eyes turning yellow), profound lethargy, sudden and severe headache, lightning headache, seizures, confusion of awareness, vision abnormalities, paralysis, urinary issues.

Mild side effects

• Dizziness
• drowsiness
• rhinitis
• increased appetite
• decreased appetite
• hypoglycemia
• confusion
• disorientation
• irritability
• depression

Store this medication in a tightly closed container to protect it from air and moisture exposure. It is important to maintain storage temperature between 15 to 30 degrees Celsius to preserve the efficacy and safety of the medication.

Appearance

A hard capsule with a brown-red upper part and a white lower part containing white powder that is white or light yellow.

Package unit

Domestic: 10 capsules/bottle, 30 capsules/bottle, 60 capsules/bottle Export: 10 capsules/bottle, 30 capsules/bottle, 60 capsules/bottle, 60 capsules (10 capsules/PTPX6)